Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling |
| |
Authors: | Gabriel Frampton Huang Li Jonathan Ramirez |
| |
Affiliation: | a Department of Internal Medicine, Texas A&M Health Science Center College of Medicine, Temple, TX, USA b Department of Hepatobiliary Surgery, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China c Digestive Disease Research Center, Scott & White Hospital, Temple, TX, USA |
| |
Abstract: | The endocannabinoids anandamide (AEA) and 2-arachidonylglycerol (2-AG) have opposing effects on cholangiocarcinoma growth. Implicated in cancer, Notch signaling requires the γ-secretase complex for activation. The aims of this study were to determine if the opposing effects of endocannabinoids depend on the differential activation of the Notch receptors and to demonstrate that the differential activation of these receptors are due to presenilin 1 containing- and presenilin 2 containing-γ-secretase complexes. Mz-ChA-1 cells were treated with AEA or 2-AG. Notch receptor expression, activation, and nuclear translocation were determined. Specific roles for Notch 1 and 2 on cannabinoid-induced effects were determined by transient transfection of Notch 1 or 2 shRNA vectors before stimulation with AEA or 2-AG. Expression of presenilin 1 and 2 was determined after AEA or 2-AG treatment, and the involvement of presenilin 1 and 2 in the cannabinoid-induced effects was demonstrated in cell lines with low presenilin 1 or 2 expression. Antiproliferative effects of AEA required increased Notch 1 mRNA, activation, and nuclear translocation, whereas the growth-promoting effects induced by 2-AG required increased Notch 2 mRNA expression, activation, and nuclear translocation. AEA increased presenilin 1 expression and recruitment into the γ-secretase complex, whereas 2-AG increased expression and recruitment of presenilin 2. The development of novel therapeutic strategies aimed at modulating the endocannabinoid system or mimicking the mode of action of AEA on Notch signaling pathways would prove beneficial for cholangiocarcinoma management. |
| |
Keywords: | 2-AG, 2-arachidonyl glycerol AEA, anandamide APH-1, anterior pharynx defective protein 1 BrdU, bromodeoxy uridine DAPI, 4&prime ,6-diamidino-2-phenylindole NICD, notch intracellular domain Pen-2, presenilin enhancer 2 SEM, standard error of the mean shRNA, short hairpin RNA |
本文献已被 ScienceDirect 等数据库收录! |
|